Prof. Dan Thomas is a Stanford trained physician scientist and clinical haematologist at the Royal Adelaide Hospital. His research is focussed on targeted therapy for myeloid malignancies. He leads the Blood Cancer Program at the South Australian Health and Medical Research Institute.

Alia Cibich is the Data Manager for the BMT Unit at Royal Adelaide Hospital, South Australia. She plays an active role in clinical research, with a special interest in late complications of transplant. Alia is currently completing a PhD investigating subsequent cancers after transplant, supported by the CALHN Dawes Scholarship.

Dr D'Souza is a senior research fellow in the cancer immunology research program at Peter MacCallum Cancer Centre. She is an immunologist and leads projects to develop new CAR-T cell therapies for T-cell lymphoma and multiple myeloma.

Dr Ally Choi is a Research Fellow at the University of Auckland working under the mentorship of A/Prof Maggie Kalev. Ally completed a PhD in bioengineering at the Australian Institute for Bioengineering and Nanotechnology, University of Queensland, before returning to Auckland to apply advanced biomaterial approaches to myeloproliferative neoplasm research.

Jeremy is a haematology registrar at the Northern Hospital Melbourne.

Jo Tan is a haematologist researching ways to improve outcomes for patients undergoing bone marrow transplantation. She has received several awards, including an NHMRC PhD Scholarship supporting her work. Jo values compassionate communication and believes strong relationships with patients and colleagues are central to better care.

Adam is a Senior Staff Specialist Haematologist at Liverpool Hospital in South Western Sydney (SWS) and a Conjoint Senior Lecturer with the University of New South Wales. He is the current President and NSW Councillor of the Haematology Society of Australia and New Zealand. At Liverpool Hospital, Adam leads the Myeloma and Plasma Cell Disorders Unit and serves as Deputy Director of the Transplant and Cellular Therapies Unit, where he is overseeing the development of the hospital’s standard-of-care CAR-T cell program for myeloma. Through the SWS Local Health District’s Haematology Clinical Research Unit, Adam has been Principal Investigator for numerous myeloma clinical trials, both industry-sponsored and collaborative. He is also a member of the Myeloma Working Party of the Australasian Leukaemia and Lymphoma Group and the Medical and Scientific Advisory Group (MSAG) of Myeloma Australia.

A/Prof Andrea Henden is a clinician-scientist with appointments as a senior staff specialist at the Royal Brisbane and Women's Hospital and as a senior research officer at QIMR Berghofer. A/Prof Henden's translational research program seeks to address complications of transplantation and cellular therapy.